secwatch.observer — SEC 8-K summary
======================================

Issuer:     DEXCOM INC (DXCM)
CIK:        0001093557
Form:       8-K
Filed at:   2022-07-28T23:59:59+00:00
Accession:  0001093557-22-000145
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Dexcom authorizes $700M share repurchase program through June 30, 2023
----------------------------------------------------------------------

- Board committee approved a share repurchase program for up to $700M of outstanding common stock.
- Repurchase period ends no later than June 30, 2023; timing depends on market conditions.
- Repurchases may be made on open market or in privately negotiated transactions; no obligation to repurchase any amount.
- Program may be extended, modified, suspended, or discontinued at any time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1093557/000109355722000145/0001093557-22-000145-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1093557/000109355722000145/dxcm-20220726.htm
  HTML page:      https://secwatch.observer/filing/0001093557-22-000145

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer